IGPK (Integrated Cannabis Solutions) Debt-to-EBITDA : N/A (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Integrated Cannabis Solutions Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Integrated Cannabis Solutions's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2025 was $0.00 Mil. Integrated Cannabis Solutions's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2025 was $0.00 Mil. Integrated Cannabis Solutions's annualized EBITDA for the quarter that ended in Jun. 2025 was $0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Integrated Cannabis Solutions's Debt-to-EBITDA or its related term are showing as below:

IGPK' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.69   Med: -1.38   Max: -1.08
Current: -1.69

During the past 2 years, the highest Debt-to-EBITDA Ratio of Integrated Cannabis Solutions was -1.08. The lowest was -1.69. And the median was -1.38.

IGPK's Debt-to-EBITDA is ranked worse than
100% of 682 companies
in the Drug Manufacturers industry
Industry Median: 1.63 vs IGPK: -1.69

Integrated Cannabis Solutions  (OTCPK:IGPK) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Integrated Cannabis Solutions Debt-to-EBITDA Related Terms

Integrated Cannabis Solutions Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Integrated Cannabis Solutions's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrated Cannabis Solutions Debt-to-EBITDA Chart

Integrated Cannabis Solutions Annual Data
Trend Dec20 Dec21
Debt-to-EBITDA
-1.08 -1.69

Integrated Cannabis Solutions Semi-Annual Data
Dec20 Dec21 Jun25
Debt-to-EBITDA -1.08 -1.69 N/A

IGPK vs CABR, BIOE, HYEX: Debt-to-EBITDA Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Integrated Cannabis Solutions's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Integrated Cannabis Solutions Debt-to-EBITDA vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Integrated Cannabis Solutions's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Integrated Cannabis Solutions's Debt-to-EBITDA falls into.


Integrated Cannabis Solutions Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Integrated Cannabis Solutions's Debt-to-EBITDA for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.553 + 0) / -0.327
=-1.69

Integrated Cannabis Solutions's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (Jun. 2025) EBITDA data.

Integrated Cannabis Solutions Business Description

Address 460 Doyle Avenue, Unit 106, Kelowna, BC, CAN, V1Y 0C2
Integrated Cannabis Solutions Inc, through its wholly-owned subsidiary, the company operates as an Internet e-commerce company through which the Company's resident merchants sell an array of consumer products on the online platform to customers located in China.